AMS verzeichnet Wachstum trotz-agent Herausforderungen Von Investing.com

In one of the latest healthcare earnings calls, American Shared Hospital Services (AMS) reports a 36% reimbursement for the 2024 quarter. The reimbursement is $6.99 million, compared to $5.13 million in the U.S. Quartal des Vorjahres. With this US dollar, a net profit of 207,000 US Dollars or 0.03 US Dollars pro Action is obtained, a return becomes a net profit of 118,000 US Dollars or 0.02 US Dollars pro Action in a quarter of 2023.

The therapies in Rhode Island and a new direction in Puebla, Mexico, were implemented. All that AMS faced with a leasing contract and the Gamma Knife treatment volumes was an employee of US$889,000 for its quarterly contract.

White Recognition

– Der Umsatz von AMS is set at 6.99 million US dollars in the quarter of 2024, an Anstieg of 36% over time.

– Shares in the trading segment of the companies have fallen 273%, while leasing revenues have sunk 16.1%.

– AMS reports net profit of US$207,000 for the quarter, compared to net profit in the 2023 quarter.

– The Unternehmen have used the quarter with 14.1 million US dollars and barmitteln and equivalents.

– This is how the strategy is written that takes on Ranjit Pradhan’s leadership and Gary Deans’ leadership for waiting lists and operational efficiency.

Unternehmensausblick

– AMS has conducted a new Wachstum on international operations and acquisitions in Rhode Island.

– The Unternehmen has developed the plan for a proton beam therapy center in Rhode Island, which means that the watch is in place.

Barische highlights

– Gamma Knife Treatment Volumes and subsequent operative costs are calculated on the basis of the delay.

– Der dem Unternehmen jijchenbare Nettoverlust betrug 207.000 US-Dollar im dretten Quartal 2024.

– Operator Verlust of 889,000 US-Dollar, a Rückgang gegenüber a leichten operator Gewinn in gleichen Quartal des Vorjahres.

Bullish highs

– Der Umsatz aus direkten Patientendienstleistungen or dem Einzelhandelssegment stieg deutlich.

– The treatment with the proton therapy is 4.4%, but the treatment lung fraction is 5.4%.

– Positive EBITDA after acquisition in Rhode Island.

Paintings

– The Gross Margin sank $1.37 million into the waiting lists in the trading segment with new Margins.

– The Gesamtumsatz with Gamma Knife sank 32.9%, influenced by the processing sauce and the Ausfallzeiten der Geräte.

Highlights of the Fragerunde

– AMS factory, the Community Commitment and the Awareness Signal for Gamma Knife Service zu strengthened.

– The Unternehmen believe that there is a kind of model and design model consisting of a regional expansion and product diversification.

– Ray Stachowiak, CEO, notes the investors on the strategic investments.

American Shared Hospital Services, with the Börsenkürzel AMS, has drawn up a strategic strategy in this quarter, einschließliche Supplies in the Führungsebene und Akquisitionen zur Stärkung des Wachstums.

Trotz der Herausforderungen ist das Unternehmen perhaps voor de Zukunft, especially in Hinblick auf de Expansion in internationaal Markte und de Entwicklung nouvelle Behandlungszentren. The management of AMS has been considered by the investors to have the knowledge and advice to solve these problems and explore the waiting strategy of the internal economy.

InvestingPro Acknowledgment

Our highly detailed complaint reports from American Shared Hospital Services (AMS) are lovely active data from InvestingPro and the associated context for investors. The reported Net Earnings in the 2024 quarter have provided InvestingPro Tipps, which can show the net profit in those years and analysts coming out, who can offer a profitable future. Stimulating the average Ausblick and the strategic writing is in the telephony conference of the Ergebnissen erwähnt wurden.

The message in the article message goes by InvestingPro-Daten weiter unterstützt, who said a value of 13.49% in the last month of the month to zum quartal 2024 and a still growing four-yearly rate of 26.72% in zweiten quartal 2024 . These dates have begun expanding and overseeing the acquisition and new developments.

Many people think they have been given an InvestingPro tip to be active in a large company, but the date is -9.52% in the market. These young reactions may explain the market reactions to the reported net overload and the broader mirror of the operative reausforderungen.

For those years you can make some interesting analyses, with InvestingPro 7 other tips for AMS, which provide an overview of the financial prosperity and market position of our external companies.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.